Topic: Manufacturing Technology

Tablets

Cipla and Nacimbio in MoU on hep C, HIV therapies

In a deal that will be closely watched, Cipla will work to transfer expertise in manufacturing to make new active pharmaceutical ingredients that treat HIV/AIDS and hepatitis C to the National Immunobiological Company.